Partnership to develop vital long-acting antimalarials for treatment and prevention
MMV brings new partner Janssen Pharmaceuticals on board
Submit your photos and videos to help end malaria
for children approved; Pyramax® granules (pyronaridine-artesunate), co-developed with Shin Poong, received positive scientific opinion from the European Medicines Agency via its Article 58 procedure
innovation award given to MMV for work on the Malaria Box
(artesunate-amodiaquine & artesunate-mefloquine), developed by DNDi and partners transitioned to MMV's portfolio
Professor Kevin Baird speaks about the challenges of delivering healthcare in Indonesia.
This infographic explains how MMV's drug discovery team works with partners to screen compounds for activity against the various stages of the parasite lifecycle.